Insider Transactions in Q1 2025 at Encompass Health Corp (EHC)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 16
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
375
+2.88%
|
$35,250
$94.38 P/Share
|
Jan 16
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
292
+5.84%
|
$27,448
$94.4 P/Share
|
Jan 15
2025
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
36
+0.18%
|
-
|
Jan 15
2025
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.18%
|
-
|
Jan 15
2025
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.19%
|
-
|
Jan 15
2025
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.17%
|
-
|
Jan 15
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.13%
|
-
|
Jan 15
2025
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.15%
|
-
|
Jan 15
2025
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
83
+0.18%
|
-
|
Jan 15
2025
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
83
+0.18%
|
-
|
Jan 15
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.14%
|
-
|
Jan 01
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,438
-17.52%
|
$1,144,296
$92.35 P/Share
|
Jan 01
2025
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,991
-16.09%
|
$275,172
$92.35 P/Share
|
Jan 01
2025
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,291
-2.24%
|
$210,772
$92.35 P/Share
|
Jan 01
2025
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,609
-5.7%
|
$2,908,028
$92.35 P/Share
|
Jan 01
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,917
-6.98%
|
$544,364
$92.35 P/Share
|
Jan 01
2025
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,446
-3.19%
|
$225,032
$92.35 P/Share
|